Hypertension Treatment Intensification Among Stroke Survivors With Uncontrolled Blood Pressure

被引:17
|
作者
Roumie, Christianne L. [1 ,2 ]
Zillich, Alan J. [3 ,4 ]
Bravata, Dawn M. [3 ,5 ,6 ,7 ]
Jaynes, Heather A. [3 ]
Myers, Laura J. [3 ,5 ,7 ]
Yoder, Joseph [3 ]
Cheng, Eric M. [8 ,9 ]
机构
[1] Tennessee Valley Healthcare Syst, Geriatr Res Educ Clin Ctr, Vet Hlth Adm, Nashville, TN USA
[2] Vanderbilt Univ, Dept Med, Nashville, TN USA
[3] Roudebush Vet Affairs Med Ctr, Ctr Hlth Informat & Commun Hlth Serv & Res Dev, Indianapolis, IN USA
[4] Purdue Univ, Dept Pharm Practice, W Lafayette, IN 47907 USA
[5] Indiana Univ Sch Med, Dept Internal Med & Geriatr, Indianapolis, IN 46202 USA
[6] Hlth Serv Res & Dev Stroke Qual Enhancement Res I, Indianapolis, IN USA
[7] Regenstrief Inst Hlth Care, Hlth Serv Res Sect, Indianapolis, IN USA
[8] Greater Los Angeles Vet Affairs Med Ctr, Dept Neurol, Los Angeles, CA USA
[9] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA
基金
美国国家卫生研究院;
关键词
health services research; hypertension; medication adherence; secondary prevention; SECONDARY PREVENTION; ISCHEMIC-STROKE; MEDICATION COMPLIANCE; PHARMACY RECORDS; VASCULAR EVENTS; PREVALENCE; PERSISTENCE; AWARENESS; VETERANS; TRENDS;
D O I
10.1161/STROKEAHA.114.007566
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-We examined blood pressure 1 year after stroke discharge and its association with treatment intensification. Methods-We examined the systolic blood pressure (SBP) stratified by discharge SBP (<= 140, 141-160, or >160 mm Hg) among a national cohort of Veterans discharged after acute ischemic stroke. Hypertension treatment opportunities were defined as outpatient SBP >160 mm Hg or repeated SBPs >140 mm Hg. Treatment intensification was defined as the proportion of treatment opportunities with antihypertensive changes (range, 0%-100%, where 100% indicates that each elevated SBP always resulted in medication change). Results-Among 3153 patients with ischemic stroke, 38% had >= 1 elevated outpatient SBP eligible for treatment intensification in the 1 year after stroke. Thirty percent of patients had a discharge SBP <= 140 mm Hg, and an average 1.93 treatment opportunities and treatment intensification occurred in 58% of eligible visits. Forty-seven percent of patients discharged with SBP 141 to160 mm Hg had an average of 2.1 opportunities for intensification and treatment intensification occurred in 60% of visits. Sixty-three percent of the patients discharged with an SBP >160 mm Hg had an average of 2.4 intensification opportunities, and treatment intensification occurred in 65% of visits. Conclusions-Patients with discharge SBP >160 mm Hg had numerous opportunities to improve hypertension control. Secondary stroke prevention efforts should focus on initiation and review of antihypertensives before acute stroke discharge; management of antihypertensives and titration; and patient medication adherence counseling.
引用
收藏
页码:465 / 470
页数:6
相关论文
共 50 条
  • [21] Blood pressure misclassification among stroke survivors followed in a comprehensive stroke prevention clinic
    Denny, M. Carter
    Almohamad, Maha
    Ebirim, Emmanuel
    Morell, Adriana
    Okpala, Munachi
    Hwang, Kevin O.
    Savitz, Sean
    Sharrief, Anjail
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2025, 34 (05):
  • [22] Prevalence and covariates of uncontrolled hypertension in ischemic stroke survivors: the Norwegian stroke in the young study
    Oftedal, Ashild
    Gerdts, Eva
    Waje-Andreassen, Ulrike
    Fromm, Annette
    Naess, Halvor
    Linde, Anja
    Saeed, Sahrai
    BLOOD PRESSURE, 2018, 27 (03) : 173 - 180
  • [23] Uncontrolled blood pressure and treatment of hypertension in older chronic kidney disease patients
    Gannon, Michael P.
    Wu, Edward
    McMahon, Gearoid M.
    Aaron, Skye
    Bates, David W.
    Waikar, Sushrut
    Samal, Lipika
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 (10) : 2985 - 2987
  • [24] Home blood pressure-based treatment with hypertension specialists: a better strategy for overcoming uncontrolled blood pressure
    Sakima, Atsushi
    HYPERTENSION RESEARCH, 2025, : 1656 - 1659
  • [25] Temporal Trends And Sociodemographic Factors In Blood Pressure Awareness, Treatment, And Control Among US Stroke Survivors
    Oh, Daniel
    Ovbiagele, Bruce
    Markovic, Daniela
    Towfighi, Amytis
    STROKE, 2022, 53
  • [26] Multiple uncontrolled conditions and blood pressure medication intensification: an observational study
    Amanda H Salanitro
    Ellen Funkhouser
    Bonita S Agee
    Jeroan J Allison
    Jewell H Halanych
    Thomas K Houston
    Mark S Litaker
    Deborah A Levine
    Monika M Safford
    Implementation Science, 5
  • [27] Multiple uncontrolled conditions and blood pressure medication intensification: an observational study
    Salanitro, Amanda H.
    Funkhouser, Ellen
    Agee, Bonita S.
    Allison, Jeroan J.
    Halanych, Jewell H.
    Houston, Thomas K.
    Litaker, Mark S.
    Levine, Deborah A.
    Safford, Monika M.
    IMPLEMENTATION SCIENCE, 2010, 5 : 1 - 9
  • [28] The ThRombolysis in UnconTrolled Hypertension (TRUTH) protocol: an observational study on treatment strategy of elevated blood pressure in stroke patients eligible for IVT
    T. P. Zonneveld
    A. Algra
    D. W. J. Dippel
    L. J. Kappelle
    R. J. van Oostenbrugge
    Y. B. W. E. M. Roos
    M. J. Wermer
    H. B. van der Worp
    P. J. Nederkoorn
    N. D. Kruyt
    BMC Neurology, 15
  • [29] The thrombolysis in uncontrolled hypertension (TRUTH) study: An observational study on treatment strategy of elevated blood pressure in stroke patients eligible for IVT
    Zonneveld, T. P.
    Algra, A.
    Dippel, D. W. J.
    Kappelle, L. J.
    van Oostenbrugge, R. J.
    Roos, Y.
    Wermer, M. J.
    van der Worp, H. B.
    Nederkoorn, P. J.
    Kruyt, N. D.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 434 - 434
  • [30] The ThRombolysis in UnconTrolled Hypertension (TRUTH) protocol: an observational study on treatment strategy of elevated blood pressure in stroke patients eligible for IVT
    Zonneveld, T. P.
    Algra, A.
    Dippel, D. W. J.
    Kappelle, L. J.
    van Oostenbrugge, R. J.
    Roos, Y. B. W. E. M.
    Wermer, M. J.
    van der Worp, H. B.
    Nederkoorn, P. J.
    Kruyt, N. D.
    BMC NEUROLOGY, 2015, 15